Center for Research in Security Prices, LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)

First Posted Date
2019-09-16
Last Posted Date
2024-05-06
Lead Sponsor
University of Chicago
Target Recruit Count
51
Registration Number
NCT04090840
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma

First Posted Date
2019-09-13
Last Posted Date
2024-05-20
Lead Sponsor
University of Chicago
Target Recruit Count
3
Registration Number
NCT04089904
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Effectiveness of Chest Compressions Under Mild Hypoxia

Not Applicable
Terminated
Conditions
Hypoxia
Cardiac Arrest
Interventions
Other: Mild hypoxia
First Posted Date
2019-08-28
Last Posted Date
2020-11-04
Lead Sponsor
University of Chicago
Target Recruit Count
19
Registration Number
NCT04072484
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable AVF Creation (FACT)

Not Applicable
Completed
Conditions
Kidney Diseases
Interventions
Device: Fist Assist
First Posted Date
2019-08-21
Last Posted Date
2023-10-12
Lead Sponsor
University of Chicago
Target Recruit Count
46
Registration Number
NCT04063787
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago Medical Center, Chicago, Illinois, United States

Intravascular Ultrasound (IVUS) Imaging During Transvenous Lead Extraction

Not Applicable
Completed
Conditions
Device Malfunction
ICD
Pacemaker Lead Dysfunction
Interventions
Device: IVUS Imaging
First Posted Date
2019-08-14
Last Posted Date
2021-12-27
Lead Sponsor
University of Chicago
Target Recruit Count
28
Registration Number
NCT04055740
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Effects of Drugs on Responses to Brain and Emotional Processes

Early Phase 1
Completed
Conditions
Autism Spectrum Disorder
Healthy
Interventions
Drug: MDMA
Drug: Placebo oral tablet
First Posted Date
2019-08-12
Last Posted Date
2024-11-25
Lead Sponsor
University of Chicago
Target Recruit Count
22
Registration Number
NCT04053036
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Thirty Million Words-Early Childhood Educator (TMW-ECE)

Not Applicable
Completed
Conditions
Language Development
Interventions
Behavioral: TMW ECE Curriculum
First Posted Date
2019-07-22
Last Posted Date
2020-04-09
Lead Sponsor
University of Chicago
Target Recruit Count
432
Registration Number
NCT04027673
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

First Posted Date
2019-06-21
Last Posted Date
2024-01-29
Lead Sponsor
University of Chicago
Target Recruit Count
51
Registration Number
NCT03995147
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)

Phase 2
Active, not recruiting
Conditions
Diffuse Large B Cell Lymphoma
Lymphoma
Interventions
Drug: Pembrolizumab
First Posted Date
2019-06-19
Last Posted Date
2024-07-11
Lead Sponsor
University of Chicago
Target Recruit Count
5
Registration Number
NCT03990961
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago Medicine, Chicago, Illinois, United States

Tracking Depression Symptoms With a Health Chatbot

First Posted Date
2019-06-19
Last Posted Date
2022-05-12
Lead Sponsor
University of Chicago
Target Recruit Count
31
Registration Number
NCT03990389
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NorthShore University HealthSystem, Skokie, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy